Text Size
24 studies found for:    CAH

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
CAH (24 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Qualitative Research on Women With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Other: Interview
2 Enrolling by invitation Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Interventions: Drug: Hydrocortisone;   Drug: Cortisone acetate
3 Completed Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   21-Hydroxylase Deficiency;   Adrenogenital Syndrome
Intervention: Drug: Chronocort for the treatment of CAH
4 Recruiting Natural History Study of Patients With Excess Androgen
Conditions: Excess Androgen;   Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
5 Unknown † Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention:
6 Unknown † Tweens to Teens Project at Penn State
Condition: Congenital Adrenal Hyperplasia
Intervention: Behavioral: Questionnaires/Interviews
7 Completed Study of UK Adults With Congenital Adrenal Hyperplasia.
Condition: Congenital Adrenal Hyperplasia
Intervention:
8 Recruiting Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention:
9 Recruiting Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Conditions: Endocrine Disease;   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia
Intervention: Drug: Hydrocortisone Modified Release Capsules
10 Recruiting Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia;   Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
11 Completed Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   Healthy
Intervention:
12 Unknown † Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Condition: Adrenal Hyperplasia, Congenital
Intervention:
13 Completed Examining Genetic Differences Among People With 21-Hydroxylase Deficiency
Condition: 21-Hydroxylase Deficiency
Intervention: Procedure: Hydrocortisone withdrawal
14 Completed Adolescence, Puberty, and Emotion Regulation
Conditions: Mood Disorder;   Neurobehavioral Manifestation;   Healthy
Intervention:
15 Active, not recruiting Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   Growth Disorder
Interventions: Drug: Flutamide and Testolactone;   Drug: Deslorelin
16 Recruiting A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency
Condition: Chronic Adrenal Insufficiency
Intervention:
17 Completed Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Nifedipine
18 Active, not recruiting Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.
Conditions: Heart Failure, Congestive;   Cardiac Pacing, Artificial;   Defibrillators
Interventions: Procedure: A;   Procedure: B
19 Recruiting Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)
Conditions: Chronic Hepatitis C;   Menopause
Intervention: Drug: Pegylated Interferon, Ribavirin, Boceprevir
20 Not yet recruiting Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment
Condition: Corneal Ulcer
Intervention: Other: Anterior lamellar nanostructured artificial human cornea.
To Top

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
† Indicates status has not been verified in more than two years